NASDAQ:IKT | Operating Income | Inhibikase Therapeutics, Inc.

Complete source-backed operating income history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Operating Income

DateOperating Income
2026-06-30-$21.05M
2026-03-31-$17.84M
2025-12-31-$13.78M
2025-09-30-$12.77M
2025-06-30-$10.83M
2025-03-31-$14.6M
2024-12-31-$12.93M
2024-09-30-$5.83M
2024-06-30-$5.05M
2024-03-31-$4.78M
2023-12-31-$4.4M
2023-09-30-$4.77M
2023-06-30-$6.2M
2023-03-31-$4.71M
2022-12-31-$4.33M
2022-09-30-$4.51M
2022-06-30-$4.64M
2022-03-31-$4.64M
2021-12-31-$5.04M
2021-09-30-$4.47M
2021-06-30-$2.63M
2021-03-31-$2.63M
2020-12-31-$1.2M
2020-09-30-$663,709.00
2020-06-30-$413,921.00
2020-03-31-$540,015.00

Annual Operating Income

DateOperating Income
2025-12-31-$51.97M
2024-12-31-$28.59M
2023-12-31-$20.09M
2022-12-31-$18.13M
2021-12-31-$14.77M
2020-12-31-$2.82M